Vaccine

Hematology·MeSH: Hemorrhagic Fever, Crimean

27 drugs in development·6 companies·1 clinical trial

Drug Pipeline by Phase

Approved(2)

Drug	Company
Ervebo	Merck & Co., Inc. (MRK)
Influvac™	ABBOTT LABORATORIES (ABT)

Phase 3(8)

Drug	Company
0.5 mL dose of PCV20	Vaxcyte, Inc. (PCVX)
20 valent pneumococcal conjugate vaccine	Vaxcyte, Inc. (PCVX)
31 valent pneumococcal conjugate vaccine	Vaxcyte, Inc. (PCVX)
31-valent pneumococcal conjugate vaccine	Vaxcyte, Inc. (PCVX)
PCV20	Vaxcyte, Inc. (PCVX)
PCV21	Vaxcyte, Inc. (PCVX)
Seasonal Influenza Vaccine	Vaxcyte, Inc. (PCVX)
vax-31	Vaxcyte, Inc. (PCVX)

Phase 2(8)

Drug	Company
0.5 ml dose of 1.1 mcg VAX-24	Vaxcyte, Inc. (PCVX)
0.5 ml dose of 2.2 mcg VAX-24	Vaxcyte, Inc. (PCVX)
0.5 ml dose of 2.2/4.4 mcg VAX-24	Vaxcyte, Inc. (PCVX)
0.5 mL of the High-PFS dose VAX-31	Vaxcyte, Inc. (PCVX)
0.5 mL of the mid dose VAX-31	Vaxcyte, Inc. (PCVX)
ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine	Arcturus Therapeutics Holdings Inc. (ARCT)
Astra Zeneca COVID-19 vaccine	Arcturus Therapeutics Holdings Inc. (ARCT)
vax-24	Vaxcyte, Inc. (PCVX)

Phase 1(4)

Drug	Company
alpha-lactalbumin breast cancer vaccine	Anixa Biosciences Inc (ANIX)
Breast cancer vaccine (α-lactalbumin)	Anixa Biosciences Inc (ANIX)
LUNAR-FLU (seasonal influenza candidate)	Arcturus Therapeutics Holdings Inc. (ARCT)
LUNAR-H5N1	Arcturus Therapeutics Holdings Inc. (ARCT)

Preclinical(1)

Drug	Company
Ovarian cancer vaccine (AMHR2-ED)	Anixa Biosciences Inc (ANIX)

Unknown(4)

Drug	Company
AviPure dsRNA Clear	REPLIGEN CORP (RGEN)
Clarithromycin (sold under Klacid™, Claribid™, Klaricid™)	ABBOTT LABORATORIES (ABT)
OPUS Pre-Packed Columns	REPLIGEN CORP (RGEN)
Vaxneuvance	Merck & Co., Inc. (MRK)

BioSniper tracks 27 drugs in development for Vaccine across 6 companies.

There are 1 clinical trial targeting Vaccine tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.